{"id":94160,"date":"2025-09-10T19:00:36","date_gmt":"2025-09-11T00:00:36","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=94160"},"modified":"2025-09-10T19:03:14","modified_gmt":"2025-09-11T00:03:14","slug":"parabens-a-dra-laura-eurelings-md-phd","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/pt\/congratulations-to-laura-eurelings-md-phd\/","title":{"rendered":"Parab\u00e9ns \u00e0 Dra. Laura Eurelings, MD, PhD!"},"content":{"rendered":"<p>No\u00a0<strong>Simp\u00f3sio M\u00e9dico sobre a Doen\u00e7a de Erdhem-Chester de 2025, em Barcelona<\/strong>, o\u00a0<strong>Pr\u00eamio ECDGA para Jovem Pesquisador<\/strong>\u00a0foi a\u00a0<strong>Laura Eurelings<\/strong>\u00a0do Centro M\u00e9dico da Universidade Erasmus, em Roterd\u00e3.<\/p>\n<p>O p\u00f4ster dela,\u00a0<em>\u201cTerapia anti-IL-6 em doen\u00e7as histioc\u00edticas raras: doen\u00e7as de Erdheim-Chester e de Rosai-Dorfman\u201d,\u201d<\/em>\u00a0mostrou que\u00a0<strong>O tocilizumabe pode ser uma op\u00e7\u00e3o eficaz para os pacientes<\/strong>, especialmente aqueles que apresentam muta\u00e7\u00e3o negativa ou que n\u00e3o s\u00e3o eleg\u00edveis para o tratamento com inibidores de BRAF.<\/p>\n<p>A participa\u00e7\u00e3o de pesquisadores em in\u00edcio de carreira traz ideias inovadoras e uma nova energia \u2014 ajudando a impulsionar o avan\u00e7o da ci\u00eancia das doen\u00e7as raras. O trabalho de Laura \u00e9 um exemplo perfeito de como os pesquisadores em in\u00edcio de carreira est\u00e3o causando um impacto real, aprimorando o conhecimento sobre a ECD!<\/p>\n<p>Junte-se a n\u00f3s para comemorar a conquista de Laura e sua contribui\u00e7\u00e3o para a comunidade de Desenvolvimento Infantil (ECD).<\/p>","protected":false},"excerpt":{"rendered":"<p>At the\u00a02025 Erdhem-Chester Disease Medical Symposium in Barcelona, the\u00a0ECDGA Junior Investigator Award\u00a0went to\u00a0Laura Eurelings\u00a0of Erasmus University Medical Centre, Rotterdam. Her poster,\u00a0\u201cAnti-IL-6 Therapy in Rare Histiocytic Disorders: Erdheim-Chester and Rosai-Dorfman Disease,\u201d\u00a0showed [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":94197,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[51],"tags":[3190,387,374,4654,2395,4254],"class_list":["post-94160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ecd","tag-ecdga","tag-erdheimchesterdisease","tag-futureofresearch","tag-medicalsymposium","tag-rarediseaseresearch"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/posts\/94160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/comments?post=94160"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/posts\/94160\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/media\/94197"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/media?parent=94160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/categories?post=94160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/pt\/wp-json\/wp\/v2\/tags?post=94160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}